Magnus C - Search Results

1

IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.

Lanz C, Schotsaert M, Magnus C, Karakus U, Hunziker A, Sempere Borau M, Martínez-Romero C, Spieler EE, Günther SC, Moritz E, Hale BG, Trkola A, García-Sastre A, Stertz S. Lanz C, et al. Among authors: magnus c. J Exp Med. 2021 Jun 7;218(6):e20200303. doi: 10.1084/jem.20200303. J Exp Med. 2021. PMID: 33882122 Free PMC article.

2

Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation.

Domingues P, Eletto D, Magnus C, Turkington HL, Schmutz S, Zagordi O, Lenk M, Beer M, Stertz S, Hale BG. Domingues P, et al. Among authors: magnus c. Nat Commun. 2019 Jul 30;10(1):3396. doi: 10.1038/s41467-019-11388-2. Nat Commun. 2019. PMID: 31363119 Free PMC article.

3

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies.

Rusert P, Krarup A, Magnus C, Brandenberg OF, Weber J, Ehlert AK, Regoes RR, Günthard HF, Trkola A. Rusert P, et al. Among authors: magnus c. J Exp Med. 2011 Jul 4;208(7):1419-33. doi: 10.1084/jem.20110196. Epub 2011 Jun 6. J Exp Med. 2011. PMID: 21646396 Free PMC article.

4

HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution.

Magnus C, Reh L, Trkola A. Magnus C, et al. Virus Res. 2016 Jun 15;218:57-70. doi: 10.1016/j.virusres.2015.10.009. Epub 2015 Oct 19. Virus Res. 2016. PMID: 26494166 Free article.

5

Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.

Brandenberg OF, Magnus C, Rusert P, Günthard HF, Regoes RR, Trkola A. Brandenberg OF, et al. Among authors: magnus c. PLoS Pathog. 2017 May 4;13(5):e1006313. doi: 10.1371/journal.ppat.1006313. eCollection 2017 May. PLoS Pathog. 2017. PMID: 28472201 Free PMC article.

6

Estimating the stoichiometry of human immunodeficiency virus entry.

Magnus C, Rusert P, Bonhoeffer S, Trkola A, Regoes RR. Magnus C, et al. J Virol. 2009 Feb;83(3):1523-31. doi: 10.1128/JVI.01764-08. Epub 2008 Nov 19. J Virol. 2009. PMID: 19019953 Free PMC article.

7

Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.

Reh L, Magnus C, Schanz M, Weber J, Uhr T, Rusert P, Trkola A. Reh L, et al. Among authors: magnus c. PLoS Pathog. 2015 Jul 9;11(7):e1004966. doi: 10.1371/journal.ppat.1004966. eCollection 2015 Jul. PLoS Pathog. 2015. PMID: 26158270 Free PMC article.

8

The HIV-1 Entry Process: A Stoichiometric View.

Brandenberg OF, Magnus C, Regoes RR, Trkola A. Brandenberg OF, et al. Among authors: magnus c. Trends Microbiol. 2015 Dec;23(12):763-774. doi: 10.1016/j.tim.2015.09.003. Epub 2015 Nov 2. Trends Microbiol. 2015. PMID: 26541228 Review.

9

Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry.

Brandenberg OF, Magnus C, Rusert P, Regoes RR, Trkola A. Brandenberg OF, et al. Among authors: magnus c. PLoS Pathog. 2015 Jan 8;11(1):e1004595. doi: 10.1371/journal.ppat.1004595. eCollection 2015 Jan. PLoS Pathog. 2015. PMID: 25569556 Free PMC article.

10

Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.

Reh L, Magnus C, Kadelka C, Kühnert D, Uhr T, Weber J, Morris L, Moore PL, Trkola A. Reh L, et al. Among authors: magnus c. PLoS Pathog. 2018 Jan 25;14(1):e1006825. doi: 10.1371/journal.ppat.1006825. eCollection 2018 Jan. PLoS Pathog. 2018. PMID: 29370298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page